DexCom, Inc. (DXCM)

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)

Market region: US

Address: 6340 Sequence Drive, San Diego, CA, 92121

Market capitalization

30.69 billion USD (30,690,131,371 USD)

Listing date

04/14/2005

Weighted shares outstanding

372,950,922

Share class shares outstanding

377,360,765

https://www.dexcom.com